Abstract:
Provided are monoclonal antibody, particularly rabbit recombinant antibody, which specifically binds to human PD-1 with biological functions and super high affinity, and methods of use. In various embodiments, the antibodies are fully humanized antibodies that bind to human PD-1. Nucleic acid molecules encoding the antibodies and methods for expressing the antibodies are also provided. In some embodiments, the antibodies are useful for inhibiting or neutralizing PD-1 activity, thus providing a means of treating, preventing and/or diagnosing a disease or disorder such as cancer or a viral infection.
Abstract:
A medical device, comprising: an array of microneedles, and a coating disposed on the microneedles, wherein the coating comprises: a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of tetracaine, ropivacaine, bupivacaine, procaine and a combination thereof; wherein the local anesthetic is present in an amount of at least 1 wt-% based upon total weight of solids in the coating, and wherein the local anesthetic and dose-extending component are in a non-eutectic weight ratio; a medical device, comprising an array of dissolvable microneedles, the microneedles comprising: a dissolvable matrix material; at least 1 wt-% of a local anesthetic selected from the group consisting of lidocaine, prilocaine, and a combination thereof; and a local anesthetic dose-extending component selected from the group consisting of tetracaine, ropivacaine, bupivacaine, procaine and a combination thereof; wherein the local anesthetic and dose-extending component are in a non-eutectic weight ratio, and wherein wt-% is based upon total weight of solids in all portions of the dissolvable microneedles which contain the local anesthetic; a method of extending a topically delivered local anesthetic dose in mammalian tissue using the devices; and methods of making the devices are provided.
Abstract:
Bei dieser Auskleidung für eine Aufzugskabine sind Tragprofile (4) vorgesehen, die an einem Kabinentragrahmen (7) angeordnet sind. Jedes Tragprofil (4) weist einen Fuss (8), einen ersten Schenkel (9) und einen zweiten Schenkel (10) auf. Der Fuss (8) ist mit dem Kabinentragrahmen (7) verbunden, die Schenkel (9, 10) laufen an ihren freien Enden zusammen und bilden eine schlitzförmige Verengung (11), durch die Paneelteile (12, 13) von Wände oder eine Decke bildenden Paneele (3) steckbar sind. Die Schenkel (9, 10) weisen Federeigenschaften auf und können entgegen einer Federkraft an der Verengung (11) auseinander bewegt werden. Die Schenkel (9, 10) halten die Paneelteile (12, 13) im Bereich der Verjüngung (11) fest.
Abstract:
Thermoplastic polymeric sheets are rendered microporous and remain substantially flat by contacting the sheet with a first fluid composition that contains or more solvents for the polymeric sheet to render the sheet microporous and then contacting the microporous sheet with a second fluid composition that is substantially free of solvents for the polymer and that contains a non-solvent that is miscible with the one or more solvents of the first composition. Contacting the microporous sheet with the second fluid composition preferably occurs prior to substantial evaporation of the first fluid compositions, or solvents thereof, from the microporous sheet.
Abstract:
A cell culture apparatus includes a substrate having formed therein a micro-well array, the micro-well array comprising a plurality of micro-wells. Each micro-well is defined by a curved surface which is concave. At least two of the micro-wells have different topgraphy.
Abstract:
A coated article having a substrate coated with a layer of silica nanoparticles is provided. The coating is substantially uniform in thickness, durably adheres to the substrate, and provides antireflection and or hydrophilic surface properties to the substrate.
Abstract:
An embodiment of the present invention includes a method comprising circulating a drilling fluid in a well bore, wherein the drilling fluid comprises a carrier fluid; and a weighting agent that comprises precipitated barite having a weight average particle diameter below about 1 micron and a particle having a specific gravity of greater than about 2.6. Another embodiment of the present invention includes a drilling fluid comprising: a carrier fluid; and a weighting agent that comprises precipitated barite having a weight average particle diameter below about 1 micron, and a particle having a specific gravity of greater than about 2.6. Another embodiment of the present invention includes a weighting agent that comprises precipitated barite having a weight average particle diameter below about 1 micron, and a particle having a specific gravity of greater than about 2.6.
Abstract:
Aspects of the present invention describe soft imprint lithography methods capable of preparing structural features on surfaces. Disclosed methods include surmounting a deformable substrate, having an original form, with a composition, wherein the deformable substrate is capable of achieving at least one predetermined deformed state; predictably deforming said deformable substrate from its original form to the at least one predetermined deformed state; and transferring at least a portion of the composition surmounting the deformed substrate to a receiving substrate.
Abstract:
The invention relates to the field of apoptosis. The invention provides novel therapeutic substances, for example novel therapeutic (non) viral vectors or proteinaceous compounds that contain apoptin in conjunction with cytotoxic agents, especially in those cases when cells are derailed such as cancer-autoimmune-derived cells.